We are live on
!
Find out more
LP
Longview Partners Portfolio holdings
AUM
$7.06B
1-Year Est. Return
3.43%
This Fund
S&P 500
This Quarter
Est. Return
-10.55%
1 Year Est. Return
-3.43%
3 Year Est. Return
+28.48%
5 Year Est. Return
+46.59%
10 Year Est. Return
+218.87%
AUM
$18.8B
AUM Growth
-$1.47B
(-7.2%)
Cap. Flow
+$695M
Cap. Flow
% of AUM
3.7%
Top 10 Holdings %
Top 10 Hldgs %
51.32%
Holding
28
New
2
Increased
5
Reduced
20
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charter Communications
CHTR
|
+$932M |
| 2 |
AGN
Allergan plc
AGN
|
+$734M |
| 3 |
W.W. Grainger
GWW
|
+$429M |
| 4 |
Parker-Hannifin
PH
|
+$268M |
| 5 |
Frontdoor
FTDR
|
+$94.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$721M |
| 2 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$404M |
| 3 |
UnitedHealth
UNH
|
+$124M |
| 4 |
Dollar General
DG
|
+$116M |
| 5 |
Aon
AON
|
+$69.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 36.63% |
| 2 | Financials | 21.84% |
| 3 | Industrials | 13.4% |
| 4 | Technology | 11.72% |
| 5 | Consumer Staples | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
HCA Healthcare
HCA
$92.8B
| $1.12B | 5.96% |
8,995,025
-408,285
| -4% | -$54.8M |
|
2
IQVIA
IQV
$40B
| $1.08B | 5.77% |
9,331,867
-208,078
| -2% | -$25.2M |
|
3
Henry Schein
HSIC
$9.76B
| $1.04B | 5.52% |
16,853,780
-554,116
| -3% | -$36.5M |
|
4
Fidelity National Information Services
FIS
$23.2B
| $993M | 5.29% |
9,684,025
-242,640
| -2% | -$25.3M |
|
|
5
Dollar General
DG
$27.8B
| $941M | 5.01% |
8,703,615
-1,075,488
| -11% | -$116M |
|
6
Willis Towers Watson
WTW
$29.9B
| $928M | 4.94% |
6,112,892
-62,711
| -1% | -$9.39M |
|
|
7
Aon
AON
$81.4B
| $904M | 4.81% |
6,218,819
-444,708
| -7% | -$69.1M |
|
|
8
W.W. Grainger
GWW
$66B
| $891M | 4.74% |
3,155,394
+1,441,615
| +84% | +$429M |
|
|
9
UnitedHealth
UNH
$389B
| $883M | 4.7% |
3,544,855
-471,063
| -12% | -$124M |
|
10
Oracle
ORCL
$346B
| $861M | 4.58% |
19,063,149
-357,100
| -2% | -$17.1M |
|
|
11
Charter Communications
CHTR
$16.7B
| $847M | 4.51% |
+2,971,157
| New | +$932M |
|
|
12
Parker-Hannifin
PH
$125B
| $839M | 4.47% |
5,626,117
+1,653,011
| +42% | +$268M |
|
|
BNY
13
Bank of New York Mellon
BNY
$106B
| $822M | 4.38% |
17,465,623
-308,190
| -2% | -$15M |
|
|
AGN
14
DELISTED
Allergan plc
AGN
| $805M | 4.29% |
6,026,108
+4,475,447
| +289% | +$734M |
|
15
Emerson Electric
EMR
$85B
| $787M | 4.19% |
13,170,336
-245,937
| -2% | -$16.6M |
|
16
Wells Fargo
WFC
$263B
| $756M | 4.02% |
16,406,922
-178,760
| -1% | -$9.16M |
|
17
State Street
STT
$50.2B
| $694M | 3.69% |
11,005,693
-197,158
| -2% | -$14.1M |
|
18
Zimmer Biomet
ZBH
$18.5B
| $669M | 3.56% |
6,644,556
-121,693
| -2% | -$13.7M |
|
19
Medtronic
MDT
$111B
| $578M | 3.08% |
6,353,455
-513,140
| -7% | -$48M |
|
20
Omnicom Group
OMC
$24.6B
| $501M | 2.67% |
6,844,843
-125,758
| -2% | -$9.33M |
|
21
US Foods
USFD
$22.3B
| $498M | 2.65% |
15,730,376
+945,238
| +6% | +$29.2M |
|
|
22
Pfizer
PFE
$144B
| $372M | 1.98% |
8,993,825
-17,374,076
| -66% | -$721M |
|
23
Thermo Fisher Scientific
TMO
$214B
| $332M | 1.77% |
1,484,698
-28,365
| -2% | -$6.66M |
|
24
TJX Companies
TJX
$178B
| $212M | 1.13% |
4,741,080
-841,256
| -15% | -$42.5M |
|
25
Arrow Electronics
ARW
$10.8B
| $198M | 1.05% |
2,866,181
+1,082
| +0% | +$77K |
|
Similar funds
IGAM
NAMA
RPI
MNA
CWM
SC
OCA
DE
Longview Partners's Q4 2018 Portfolio in Review
As of Q4 2018, Longview Partners held 28 positions worth $18.8B, down 7.2% from $20.3B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Longview Partners deployed $695M of net new capital in Q4 2018, opening 2 new positions and adding to 5 existing holdings. Its largest new stake was Charter Communications: 2,971,157 shares worth $847M.
By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 40% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Pfizer, an estimated $721M trimmed.
- Longview Partners's largest Q4 2018 buy was Charter Communications: 2,971,157 shares worth $847M.
- Longview Partners added most to Allergan plc in Q4 2018, an estimated $734M increase.
- Longview Partners's biggest Q4 2018 reduction was Pfizer, cutting an estimated $721M.
- Longview Partners fully exited Terminix Global Holdings, Inc. in Q4 2018, selling an estimated $404M.
- Longview Partners's ten largest holdings make up 51% of its $18.8B portfolio in Q4 2018.
- Longview Partners opened 2 new positions and closed 1 in Q4 2018.
- Longview Partners's portfolio value fell 7.2% quarter-over-quarter to $18.8B.
Based on Longview Partners's 13F filing for Q4 2018, filed 13 Feb 2019.